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Abstract 
The present study was conducted on 78 cases in the Department of Medicine at G.S.V.M Medical College, Kanpur 
who reported with various gastrointestinal symptoms such as dyspepsia, heartburns, nausea, vomiting and loss 
of appetite. They all were advised for biopsy by the physician. Patients treated with antibiotics, bismuth or proton 
pump inhibitors within 4 weeks preceding the study were excluded. Invasive tests using mucosal biopsies including 
histology and rapid urease test (RUT) were used to establish the gold standard in order to evaluate the accuracy 
of Immunocard STAT HpSA. Sensitivity, Specificity, Positive Predictive Value and Negative Predictive Value of 
Immunocard STAT HpSA as compared to gold standard were 95.5%, 81.8%, 96.9% and 75.0% respectively. It is 
thus concluded that the Immunocard STAT HpSA test has a diagnostic value comparable to the gold standard in 
detecting H Pylori. The sensitivity and specificity of the test is fair enough to be used as a test for screening purpose 
and also for diagnosis and treatment of H. Pylori infection in clinical practice 
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Introduction  
Helicobacter Pylori infection is a major cause of 
chronic gastritis and peptic ulcer, and is associated 
with gastric cancer (1,2,3). It is estimated that about 
50% of the World’s population has H. Pylori 
colonization in the gastric mucosa (4). There are 
several methods of diagnosing H. Pylori infection 
including invasive procedures using mucosal biopsies 
taken during endoscopy (mainly histology and rapid 
urease test) and non-invasive procedures (mainly 
13C urea breath tests and serological tests). But 
invasive procedures like biopsy, endoscopy and urea 
breath tests require expensive equipment or are 
harmful to patients. Also the serological tests lack 
sensitivity and specificity as H. Pylori antibody titres 
fall very slowly even after successful eradication (5, 
6). 
Aims & Objectives 
To evaluate the clinical value of a new test, 
Immunocard STAT HpSA for the diagnosis of H. Pylori 
infection. 
Material and Methods 
A total of 78 patients participated in the study. All 
these patients reported with various gastrointestinal 
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symptoms such as dyspepsia, heartburns, nausea, 
vomiting and loss of appetite. They were all advised 
for biopsy by the physician. Patients treated with 
antibiotics, bismuth or proton pump inhibitors 
within 4 weeks preceding the study and those with 
bleeding peptic ulcer or past gastric surgery were 
excluded. Invasive tests using mucosal biopsies 
including histology and rapid urease test (RUT) were 
used to establish the gold standard in order to 
evaluate the accuracy of Immunocard STAT HpSA. 
During upper GI endoscopy, three gastric biopsies 
were done from the antrum of the stomach, one for 
(RUT) rapid urease test and remaining two for 
staining. The gold standard for presence of H. Pylori 
infection was defined as both RUT and staining 
positive. The absence of H. Pylori infection required 
these tests to be negative. 
Immunocard STAT HpSA – On the same day of 
endoscopy, 10 ml of the patient’s stool was collected 
into a clean air-tight container, with no 
preservatives. The stool was shifted immediately to 
the laboratory. The stool assay was performed using 
the Immunocard STAT HpSA (Standard Diagnostic 
Inc). Stool samples were collected in air tight 
containers. The stool assay was performed using 
immunocard STAT HpSA. The positive and negative 
results were judged as recommended by the 
manufacturers. This test was being used for 
screening of the subjects for H. Pylori Infection. The 
test device and the sample were brought to room 
temperature prior to testing. The test device was laid 
on a flat dry surface and about three drops of the 
prepared sample were poured into the sample well. 
Interpretation was done after fifteen minutes. Two 
colour bands, one at test band and another at 
control band indicated a positive result. Negative 
test results showed only control band. The 
endoscopy based tests and HpSA test were carried 
out by different people with double blind 
procedures. Statistical Analysis – Specificity, 
sensitivity, PPV and NPV of the HpSA test in 
comparison to gold standard were calculated using 
SPSS 20.0. 
Results 
A total of 78 patients were tested by Immunocard 
STAT HpSA and the endoscopy based tests. Among 
these, H. Pylori infection was present in 67 patients 
as determined by gold standard. HpSA test was 
positive in 64 and negative in 3 patients. Compared 
with gold standard the HpSA gave false positive in 2 
and false negative in 3 patients. Sensitivity, 
Specificity, Positive Predictive Value and Negative 
Predictive Value of Immunocard STAT HpSA were 
then calculated (Table 1). 
Sensitivity = 64/67 x 100   = 95.5% 
Specificity = 9/11 x 10 = 81.8%s 
Positive Predictive value = 64/66 x 100 = 96.9% 
Negative Predictive value = 9/12x100 = 75.0% 
Discussion  
Various invasive tests are available to diagnose H. 
Pylori infection. Though these tests are highly 
sensitive and specific but have certain limitations. 
Mucosal biopsies taken during endoscopy might lead 
to cross – infection and sometimes patients refuse to 
undergo endoscopy especially the pediatric patients. 
The urea Breath Tests have proven to have high 
sensitivity and specificity and are considered to be 
the optimal test for monitoring H. Pylori eradication 
therapy. However, 13C-UBT need special equipment 
and is expensive and 14C-UBT requires a radioactive 
isotope; and cannot be used for children and 
pregnant women. So, UBTs are not widely available. 
Due to these reasons, HpSA STAT test is better as it 
is easy, cheaper and accurate. Gastric epithelial cells 
renew once in one to three day which are excreted 
in feces with H. Pylori which can be detected by 
polyclonal capture anti H. Pylori antibodies, (7). The 
HpSA test has been widely evaluated around the 
World with a mean sensitivity and specificity of 90 – 
98% respectively, (8,9). The HpSA test is a cheap and 
useful method for the diagnosis of H. Pylori infection 
before and after eradication therapy (10). It is an 
accurate test in all paediatric age groups also, (11). 
Although HpSA test seems to be less accurate than 
the urea breath test (UBT), both UBT and stool 
antigen tests are reliable non-invasive tests for 
monitoring the efficacy of H. Pylori eradication 
therapy (7). 
Conclusion 
In the present study, we conclude that the 
Immunocard STAT HpSA test has a diagnostic value 
comparable to the gold standard in detecting H. 
Pylori. The sensitivity and specificity of the test is fair 
enough to be used as a test for screening purpose 
and also for diagnosis and treatment of H. Pylori 
infection in clinical practice. Also it is easy and 
convenient to perform and can be used especially for 
children, pregnant women, old people and others 
who are not suitable for endoscopy. 
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Recommendation 
Immunocard STAT HpSA is a very sensitive and fairly 
specific tool to identify cases of H. Pylori in the 
general population. It is non-invasive and easy to 
perform, therefore it is recommended as the ideal 
investigation for screening of cases of H. Pylori. 
Limitation of the study 
The limitations of the study are that the sample size 
is small and that it is a hospital based study. Further 
community based studies can be done to confirm the 
findings of the study. 
Relevance of the study 
There is a high prevalence of H. Pylori infection in the 
general population. Most of these cases are 
undiagnosed and use over the counter antacids for 
dyspepsia. A simple and convenient test like 
Immunocard STAT HpSA will be very useful in 
diagnosis and correct management of these cases. 
Earlier the diagnosis of H. Pylori infection was 
possible only on the basis of biopsy and 
histopathology, but with the evidence that 
Immunocard HpSA STAT test is very sensitive and 
specific as compared to biopsy and histopathology, 
this test can be recommended as the screening tool 
for diagnosis of H. Pylori infection. 
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TABLE 1 PERFORMANCE OF THE IMMUNOCARD STAT HPSA TEST IN THE DETECTION OF H. PYLORI 
INFECTION, ACCORDING TO THE BIOPSY BASED GOLD STANDARD. 
Immunocard STAT HpSA Gold standard 
Positive Negative Total 
Positive 64 2 66 
Negative  3 9 12 
Total 67 11 78 
 
